<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30529" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Trapped Lung</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Upadrista</surname>
            <given-names>Pratap Kumar</given-names>
          </name>
          <aff>Nassau University Medical Centre</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sabbula</surname>
            <given-names>Bhanusivakumar R.</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Akella</surname>
            <given-names>Jagadish</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pratap Kumar Upadrista declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhanusivakumar Sabbula declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jagadish Akella declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30529.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The trapped lung is defined as the lung's inability to expand and fill the thoracic cavity because of a fibrinous restrictive pleural layer that prevents normal visceral and parietal pleural apposition. It is caused by remote inflammation of the pleura and typically presents as chronic stable pleural effusion. To avoid the high morbidity associated with multiple invasive diagnostic procedures, it must be promptly diagnosed and treated. This activity reviews the etiology, evaluation, and treatment of trapped lungs and highlights the role of interprofessional diagnosis, timely evaluation, and management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the concept of the non-expandable lung.</p></list-item><list-item><p>Assess the evaluation of the patient's trapped lung.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment and management options available for trapped lungs.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30529&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30529">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30529.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Non-expandable lung (NEL) is a term used to describe entities characterized by the lung's inability to expand into the chest cavity or respective pleural space. There are&#x000a0;3 distinct causes of NEL: a) An endobronchial lesion obstructing the lumen of the bronchus leading to the distal lobar collapse, b) chronic atelectasis, and c) visceral pleural restriction due to pleural disease resulting in the trapped lung. The trapped lung,&#x000a0;first described in 1967, is a clinical entity characterized by a restrictive visceral pleura.<xref ref-type="bibr" rid="article-30529.r1">[1]</xref>&#x000a0;A trapped lung occurs as a mature fibrous strip encircles the visceral pleura, restricting lung expansion, which develops from inflammatory sequelae.&#x000a0;The usual primary causes of pleural inflammation are pneumonia or hemothorax, but other causes like pneumothorax, thoracic surgical interventions, uremia, and autoimmune diseases like rheumatoid pleuritis are also well established.<xref ref-type="bibr" rid="article-30529.r2">[2]</xref><xref ref-type="bibr" rid="article-30529.r3">[3]</xref><xref ref-type="bibr" rid="article-30529.r4">[4]</xref>&#x000a0;In clinical practice, a patient with a trapped lung commonly presents&#x000a0;with chronic pleural effusion. Repeated thoracenteses, without lung re-expansion post-procedure, can result in adverse events.</p>
      </sec>
      <sec id="article-30529.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Historically,&#x000a0;pneumothorax therapy, used to treat tuberculosis, had caused trapped lungs.<xref ref-type="bibr" rid="article-30529.r2">[2]</xref><italic toggle="yes">&#x000a0;</italic>The most common&#x000a0;etiologies include immunologic diseases such as rheumatoid pleurisy, inflammatory pleuritis, improperly drained hemothorax,&#x000a0;parapneumonic effusions, and infections like bacterial empyema, tuberculous pleurisy, malignant pleural effusions, asbestos exposure, uremic pleurisy,&#x000a0;post-cardiac surgery, chest radiation, and medications.<xref ref-type="bibr" rid="article-30529.r5">[5]</xref><xref ref-type="bibr" rid="article-30529.r6">[6]</xref></p>
      </sec>
      <sec id="article-30529.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is unclear why some patients with pleural inflammation heal without sequela while others develop a restrictive fibrous visceral peel&#x000a0;leading to the trapped lung. The exact incidence of trapped lung is poorly documented, but it&#x000a0;is expected to be higher than is generally recognized. A study by Dresler et al&#x000a0;suggests that among patients who undergo thoracentesis, approximately 10% have non-expandable lungs, 20% of patients who undergo therapeutic thoracentesis, and 30% of those who undergo therapeutic thoracentesis for malignant pleural effusion have non-expandable lung.<xref ref-type="bibr" rid="article-30529.r7">[7]</xref></p>
      </sec>
      <sec id="article-30529.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>A restricting peel prevents normal parietal and visceral pleural layer apposition in&#x000a0;a trapped lung. The formation of this fibrous restrictive peel requires the presence of a long-standing stable pleuro-pulmonary disease, either from an inflamed lung or a malignant visceral pleural tumor.<xref ref-type="bibr" rid="article-30529.r3">[3]</xref>&#x000a0;This fibrotic restrictive visceral pleura prevents the lung from expanding when pleural fluid is removed during thoracocenteses. Negative pleural pressure within the pleural space increases fluid entry into the pleural space. It reduces pleural fluid exit through pleural lymphatics, thus leading to the formation of a chronic pleural effusion. So, a steady state of fluid formation and removal is established, leading to persistent negative pressure pleural effusion of constant volume. This persistence of the pleural effusion is mainly mechanical and can be considered a "pleural effusion ex-vacuo".<xref ref-type="bibr" rid="article-30529.r2">[2]</xref><xref ref-type="bibr" rid="article-30529.r4">[4]</xref></p>
      </sec>
      <sec id="article-30529.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Symptoms vary depending on the size of the pleural effusion. Patients can be asymptomatic with small effusions and are&#x000a0;noticed&#x000a0;incidentally on imaging studies like a chest x-ray and&#x000a0;computed tomography&#x000a0;of the chest or abdomen. Clinical exam shows&#x000a0;ipsilateral: decreased breath sounds, stony, dull percussion, and decreased fremitus. When the effusion is significant enough, it can cause respiratory&#x000a0;distress&#x000a0;and warrant immediate relief through thoracentesis or even a surgical approach. Patients experience discomfort&#x000a0;during the thoracentesis owing to further reductions in intrathoracic pressure. Lung entrapment, on the other hand, is an active inflammatory process presenting as&#x000a0;chest pain and severe dyspnea. Trapped lung poses a significant risk for inadvertent multiple diagnostic and therapeutic procedures attempted&#x000a0;for chronic stable pleural effusion, leading to further complications. Hence, a trapped lung should be considered early in the differential diagnosis of chronic stable pleural effusion when no clinically apparent active disease is found.<xref ref-type="bibr" rid="article-30529.r2">[2]</xref><xref ref-type="bibr" rid="article-30529.r5">[5]</xref></p>
      </sec>
      <sec id="article-30529.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The pleural fluid analysis in a trapped lung is consistent with a transudate or a protein-discordant exudate and has a paucicellular mononuclear cell predominance. Pleural fluid LDH is low, and protein may be in the exudative range. The elevated total pleural fluid protein may be related to factors other than active pleural inflammation or malignancy and does not exclude the diagnosis. The characteristic diagnostic clue is that the pleural effusion reaccumulates rapidly after thoracocenteses, and the effusion volume due to the trapped lung remains remarkably constant. A high index of suspicion should be maintained in diagnosing and managing trapped lungs, particularly in malignant pleural effusions, to prevent complications from repeated thoracenteses. Repeated thoracenteses can result in various complications like chest pain, the formation of loculations, bleeding, the development of hemothorax, and also recurrent effusions. Trapped lung should be suspected in any patient who presents with a stable chronic pleural effusion, particularly if there is an antecedent history of pneumonia, pneumothorax, thoracic surgery, or hemothorax.<xref ref-type="bibr" rid="article-30529.r8">[8]</xref><xref ref-type="bibr" rid="article-30529.r9">[9]</xref><xref ref-type="bibr" rid="article-30529.r10">[10]</xref></p>
        <p>
<bold>Pleural Manometry&#x000a0;</bold>
</p>
        <p>The trapped lung is can be diagnosed via pleural manometry during thoracentesis. As it is time-consuming and requires technical expertise, currently, manometry is not routinely used during thoracentesis. With large-volume thoracentesis, pleural elastance changes throughout the procedure. It predicts successful pleurodesis by measuring the absolute closing pressure and overall elastance. When the elastance is high, the probability of the pleural layers being pulled apart increases, interfering with pleurodesis. In the setting of a trapped lung, despite a&#x000a0;pleural&#x000a0;effusion, the&#x000a0;pleural pressure&#x000a0;is low and drops significantly with fluid removal. This high&#x000a0;pleural&#x000a0;elastance (change in&#x000a0;pressure/volume) is a hallmark of a trapped lung. These characteristic pleural pressure changes are highly suggestive of a trapped lung. It may aid in the diagnosis of patients with minimal or absent symptoms. However, confirmation with&#x000a0;direct visualization via video-assisted thoracoscopy or air contrast&#x000a0;computed tomography showing visceral pleural thickening (a pleural rind) is required.</p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Upright and decubitus radiographs and chest computed tomography often show pleural thickening and loculations. Pleural fluid may shift slightly with postural changes but&#x000a0;isn't&#x000a0;free-flowing. The paradoxical finding that the hemithorax with pleural effusion is reduced in size compared to the contralateral side suggests significantly higher negative pleural pressure on the affected side than on the opposite side. It provides further evidence for the diagnosis of a trapped lung. Post-thoracentesis radiographs may show air in the pleural space with the same size and shape as the prior effusion.<xref ref-type="bibr" rid="article-30529.r10">[10]</xref></p>
        <p>
<bold>Ultrasound</bold>
</p>
        <p>Point-of-care ultrasound (POCUS)is a rapid, bedside, cost-effective way to diagnose pleural pathologies and&#x000a0;must&#x000a0;be performed before any pleural intervention. With the patient positioned upright or supine, a low-frequency, 2- to 5-MHz transducer probe is placed in a longitudinal orientation. With the probe marker held cranially from mid-axillary or posterior mid-scapular views, images are viewed in brightness and motion modes. In motion mode, the respiratory movement of an atelectatic lung occurs in a sinusoidal pattern within the surrounding pleural fluid. This represents a &#x0201c;sinusoid sign," which suggests the expandable lung. The absence of this sinusoidal respirophasic lung is known as an &#x0201c;absent sinusoid sign". It suggests an unexpandable lung and coincides with pleural manometry findings.<xref ref-type="bibr" rid="article-30529.r11">[11]</xref>&#x000a0;Besides this, thoracic ultrasound is useful for differentiating between malignant and benign diseases, pleural thickening, nodularity, and lung consolidation with or without effusion.<xref ref-type="bibr" rid="article-30529.r12">[12]</xref></p>
      </sec>
      <sec id="article-30529.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are various treatment options&#x000a0;for trapped lungs, and the patient's symptoms determine&#x000a0;the choice of treatment modality. Observation is warranted in an asymptomatic patient if the effusion is not worsening.<xref ref-type="bibr" rid="article-30529.r4">[4]</xref>&#x000a0;If the patient has dyspnea, symptom alleviation can be achieved through fluid removal via thoracentesis.<xref ref-type="bibr" rid="article-30529.r13">[13]</xref>&#x000a0;In patients with a poor prognosis and a shorter expected survival period, repeated thoracentesis or a pleural catheter is advised as the least invasive approach to provide immediate symptom relief. Complications include rapid re-accumulation requiring multiple visits, infection leading to empyema, worsening pneumothorax, hemothorax, and bleeding.<xref ref-type="bibr" rid="article-30529.r14">[14]</xref><xref ref-type="bibr" rid="article-30529.r15">[15]</xref></p>
        <p>
<bold>Implantable Pleural Catheter</bold>
</p>
        <p>Pleurodesis is considered an effective therapeutic choice for patients with malignant, recurrent pleural effusion. However, pleurodesis is ineffective and not the management of choice in cases of trapped lungs.<xref ref-type="bibr" rid="article-30529.r16">[16]</xref>&#x000a0;A chronic indwelling pleural catheter can be considered for symptomatic relief in these patients.&#x000a0;This is a small-bore catheter 66 cm long, 15 F silicone rubber catheter with fenestrations along the distal 24 cm, placed within the pleural space. It aids in partial lung expansion and alleviates symptoms, as dyspnea in these patients is predominantly due to pleural space tension relative to the chest wall and diaphragm rather than parenchymal lung pathology or lung collapse.<xref ref-type="bibr" rid="article-30529.r17">[17]</xref><xref ref-type="bibr" rid="article-30529.r15">[15]</xref><xref ref-type="bibr" rid="article-30529.r18">[18]</xref></p>
        <p>
<bold>Pleuroperitoneal Shunt</bold>
</p>
        <p>The pleuroperitoneal shunt, proposed in 1982 by Weese and Schouten, can provide effective and safe palliation in select patients. With each compression, it can transport up to 1.5 L of pleural fluid into the abdominal cavity. Complications include shunt failure and infection and are not routinely recommended or preferred.<xref ref-type="bibr" rid="article-30529.r19">[19]</xref><xref ref-type="bibr" rid="article-30529.r20">[20]</xref><xref ref-type="bibr" rid="article-30529.r21">[21]</xref></p>
        <p>
<bold>Surgical Decortication&#x000a0;</bold>
</p>
        <p>Surgical decortication is the only curative treatment modality when a more definitive approach is indicated.<xref ref-type="bibr" rid="article-30529.r4">[4]</xref>&#x000a0;It involves removing a fibrous visceral pleural layer covering the lung to allow lung expansion.<xref ref-type="bibr" rid="article-30529.r22">[22]</xref>&#x000a0;Pleura can now oppose the chest wall, and this relieves restrictive ventilatory defect, thus having a positive impact on hypoxia and ventilation-perfusion mismatch. It also reduces chest wall pain, discomfort, and dyspnea and prevents recurrent pleural effusions. It is important to exclude other diseases and underlying cardiopulmonary conditions before attempting surgical decortication. Visceral pleurectomy can be performed by either open thoracotomy or the most preferred minimally invasive approach, Video-assisted thoracoscopic surgery (VATS).<xref ref-type="bibr" rid="article-30529.r23">[23]</xref><xref ref-type="bibr" rid="article-30529.r24">[24]</xref>&#x000a0;VATS is a minimally invasive surgical technique to diagnose and treat pleuro-parenchymal diseases. A tiny camera (thoracoscope) and surgical instruments are inserted into your chest through&#x000a0;1 or more small incisions in&#x000a0;the chest wall during a VATS procedure.</p>
        <p>
<bold>Intrapleural Fibrinolytic Therapy</bold>
</p>
        <p>In select cases, fibrinolytic drugs such as tPA, urokinase, and streptokinase can be introduced into the pleural space to break down fibrin strands and adhesions and promote drainage and expansion of the lung. These can be used as palliative care options in inoperable scenarios.<xref ref-type="bibr" rid="article-30529.r25">[25]</xref>&#x000a0;All of these treatment options are, in essence, palliative. Re-expansion of the lung, even after removing this peel, is difficult when the lung has been trapped for a long time.<xref ref-type="bibr" rid="article-30529.r4">[4]</xref></p>
      </sec>
      <sec id="article-30529.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is important to differentiate the trapped lung from lung entrapment to identify active processes requiring specific treatment and avoid unnecessary diagnostic and therapeutic pleural procedures in patients with trapped lungs. Lung entrapment may result from pleural or non-pleural causes, while the trapped lung is caused only by pleural causes. Non-pleural causes that cause lung entrapment include conditions that increase the elastic recoil pressure of the lung.&#x000a0;They include endobronchial obstruction due to bronchogenic carcinoma or interstitial diseases like lymphangitic carcinomatosis<xref ref-type="bibr" rid="article-30529.r26">[26]</xref>. The pleural fluid analysis is usually consistent with exudate in lung entrapment, while patients with trapped lungs have a transudate or a protein-discordant exudate with a mononuclear cell predominance.&#x000a0;Furthermore, these entities can be differentiated by the particular patterns of pleural elastance.&#x000a0;Unlike trapped lung, pleural manometry in lung entrapment shows normal elastance during initial pleural fluid removal. Still, the lung doesn't expand fully as more fluid is removed and the slope of the elastance curve increases. While most cases of lung entrapment resolve with the resolution of the inflammatory process, the resolution is incomplete in a trapped lung. Therefore, a trapped lung and lung entrapment can represent a continuum of the same process. Other differentials include pneumothorax ex-vacuo (particularly right upper lobe collapse), cryptogenic organizing pneumonia, chronic pulmonary consolidations, and bronchiolitis obliterans organizing pneumonia.<xref ref-type="bibr" rid="article-30529.r27">[27]</xref></p>
      </sec>
      <sec id="article-30529.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The trapped lung is an independent risk factor for short survival compared to patients without non-expandable lungs in mesothelioma patients.<xref ref-type="bibr" rid="article-30529.r28">[28]</xref>&#x000a0;Bibby and colleagues found that in a cohort of 229 patients, 33% of patients with Malignant Pleural Mesothelioma have a non-expandable lung. Perhaps most importantly, they have found for the first time that non-expandable lung is an independent predictor of poor survival.<xref ref-type="bibr" rid="article-30529.r29">[29]</xref>&#x000a0;It is unclear as to why it has an effect on the survival rate, and further studies are warranted.</p>
      </sec>
      <sec id="article-30529.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Undiagnosed trapped lung typically presents as chronic stable pleural effusion, and these patients might undergo multiple thoracocenteses without any significant improvement in respiratory symptoms. Repeated thoracenteses can lead to many adverse events related to&#x000a0;the procedure, delay in diagnosis and adequate treatment, improper use of resources, worsening of the underlying disease, and above all, significant&#x000a0;patient discomfort.<xref ref-type="bibr" rid="article-30529.r11">[11]</xref></p>
      </sec>
      <sec id="article-30529.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The main risk in trapped lung patients is multiple diagnostic and therapeutic procedures for a persistent pleural effusion. This can be prevented by clinical awareness of this condition. The patient should be counseled regarding the benign nature of the trapped lung once the underlying malignancy is excluded and the irreversible outcome of this pleural abnormality. Further diagnostic or therapeutic interventions should be avoided unless the radiographical appearance changes, and patients should be educated to reduce the risk of undergoing an ill-advised intervention in the future.</p>
      </sec>
      <sec id="article-30529.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about trapped lungs are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Knowledge of trapped lungs is crucial for physicians as many of these patients are subjected to repeated thoracentesis, managed with chest tubes, resulting in prolonged hospitalization.</p>
          </list-item>
          <list-item>
            <p>A trapped lung should be suspected in any patient with a chronic stable pleural effusion, particularly if there is a history of pneumonia, pneumothorax,&#x000a0;hemothorax, thoracic surgery, or&#x000a0;malignancy.</p>
          </list-item>
          <list-item>
            <p>Ultrasound is a rapid and cost-effective way of diagnosing pleural effusion.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Once a trapped lung is diagnosed, pleural drainage must be assessed based on the clinical circumstances on a case-by-case basis.<xref ref-type="bibr" rid="article-30529.r11">[11]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>High&#x000a0;pleural space elastance (change in&#x000a0;pressure/change in volume) exceeding 14.5 cm HO/L is the hallmark of&#x000a0;a trapped lung.<xref ref-type="bibr" rid="article-30529.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Decortication of visceral pleura by VATS might allow reexpansion of the trapped lung to some degree and aid in resolving the trapped lung.<xref ref-type="bibr" rid="article-30529.r22">[22]</xref><xref ref-type="bibr" rid="article-30529.r30">[30]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30529.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The outcomes of a trapped lung depend on the underlying cause. Prompt consultation with a pulmonologist, thoracic surgeon, or an intervention radiologist is highly recommended to improve outcomes. Clinicians should have a high index of suspicion for trapped lung when they encounter a chronic stable pleural effusion with no apparent diagnosis.&#x000a0;Radiologists play a vital role in identifying the thickened rind of visceral pleura in imaging studies.&#x000a0;Patient education is extremely important, and an interdisciplinary discussion must be held with the patient and their caregivers for better outcomes. Oncologists and surgical pathologists must be involved in caring for patients with underlying malignancies.<xref ref-type="bibr" rid="article-30529.r3">[3]</xref></p>
      </sec>
      <sec id="article-30529.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30529&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30529">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/trapped-lung/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30529">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30529/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30529">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30529.s16">
        <title>References</title>
        <ref id="article-30529.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>The trapped lung with chronic pleural space, a cause of recurring pleural effusion.</article-title>
            <source>Mil Med</source>
            <year>1967</year>
            <month>Dec</month>
            <volume>132</volume>
            <issue>12</issue>
            <fpage>998</fpage>
            <page-range>998-1002</page-range>
            <pub-id pub-id-type="pmid">4966241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doelken</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Trapped lung.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>631</fpage>
            <page-range>631-6</page-range>
            <pub-id pub-id-type="pmid">16088707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Doelken</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The unexpandable lung.</article-title>
            <source>F1000 Med Rep</source>
            <year>2010</year>
            <month>Oct</month>
            <day>21</day>
            <volume>2</volume>
            <fpage>77</fpage>
            <pub-id pub-id-type="pmid">21173837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereyra</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ferreiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Unexpandable lung.</article-title>
            <source>Arch Bronconeumol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>63</fpage>
            <page-range>63-9</page-range>
            <pub-id pub-id-type="pmid">22749682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Heidecker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ravenel</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Doelken</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of trapped lung: pleural fluid analysis, manometry, and air-contrast chest CT.</article-title>
            <source>Chest</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>206</fpage>
            <page-range>206-13</page-range>
            <pub-id pub-id-type="pmid">17218577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopic decortication for the management of trapped lung caused by 14-year pneumothorax: A case report.</article-title>
            <source>Thorac Cancer</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>1074</fpage>
            <page-range>1074-1077</page-range>
            <pub-id pub-id-type="pmid">29802756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dresler</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Olak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herndon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Scalzetti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fleishman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kernstine</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Demmy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jablons</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kohman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Haasler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>DJ</given-names>
              </name>
              <collab>Cooperative Groups Cancer and Leukemia Group B</collab>
              <collab>Eastern Cooperative Oncology Group</collab>
              <collab>North Central Cooperative Oncology Group</collab>
              <collab>Radiation Therapy Oncology Group</collab>
            </person-group>
            <article-title>Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>909</fpage>
            <page-range>909-15</page-range>
            <pub-id pub-id-type="pmid">15764775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Jenkinson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Minh</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1980</year>
            <month>May</month>
            <volume>121</volume>
            <issue>5</issue>
            <fpage>799</fpage>
            <page-range>799-804</page-range>
            <pub-id pub-id-type="pmid">7406313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Schwartzstein</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Assessment of pleural pressure in the evaluation of pleural effusions.</article-title>
            <source>Chest</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>135</volume>
            <issue>1</issue>
            <fpage>201</fpage>
            <page-range>201-209</page-range>
            <pub-id pub-id-type="pmid">19136407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villena</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Encuentra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pozo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De-Pablo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-Escribano</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Measurement of pleural pressure during therapeutic thoracentesis.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>162</volume>
            <issue>4 Pt 1</issue>
            <fpage>1534</fpage>
            <page-range>1534-8</page-range>
            <pub-id pub-id-type="pmid">11029373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patail</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Absent Sinusoid Sign.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>506</fpage>
            <page-range>506-508</page-range>
            <pub-id pub-id-type="pmid">30932704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qureshi</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>FV</given-names>
              </name>
            </person-group>
            <article-title>Thoracic ultrasound in the diagnosis of malignant pleural effusion.</article-title>
            <source>Thorax</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-43</page-range>
            <pub-id pub-id-type="pmid">18852159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pien</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Gant</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Washam</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Sterman</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.</article-title>
            <source>Chest</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>119</volume>
            <issue>6</issue>
            <fpage>1641</fpage>
            <page-range>1641-6</page-range>
            <pub-id pub-id-type="pmid">11399685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Neville</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berrisford</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>NJ</given-names>
              </name>
              <collab>BTS Pleural Disease Guideline Group</collab>
            </person-group>
            <article-title>Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.</article-title>
            <source>Thorax</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>65 Suppl 2</volume>
            <fpage>ii32</fpage>
            <page-range>ii32-40</page-range>
            <pub-id pub-id-type="pmid">20696691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Walkey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berkowitz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The relationship of pleural pressure to symptom development during therapeutic thoracentesis.</article-title>
            <source>Chest</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>1556</fpage>
            <page-range>1556-60</page-range>
            <pub-id pub-id-type="pmid">16778274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant pleural effusions.</article-title>
            <source>Monaldi Arch Chest Dis</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>56</volume>
            <issue>5</issue>
            <fpage>394</fpage>
            <page-range>394-9</page-range>
            <pub-id pub-id-type="pmid">11887496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Estenne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yernault</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>De Troyer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions.</article-title>
            <source>Am J Med</source>
            <year>1983</year>
            <month>May</month>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>813</fpage>
            <page-range>813-9</page-range>
            <pub-id pub-id-type="pmid">6837605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertolaccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paiano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pomari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Assante</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Terzi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">27865327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Genc</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ladas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Goldstraw</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-6</page-range>
            <pub-id pub-id-type="pmid">10925221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goldstraw</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting.</article-title>
            <source>Cancer</source>
            <year>1995</year>
            <month>Feb</month>
            <day>01</day>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>801</fpage>
            <page-range>801-5</page-range>
            <pub-id pub-id-type="pmid">7530167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludwig</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stoelben</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Surgical therapy for malignant pleural effusions].</article-title>
            <source>Zentralbl Chir</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>3</issue>
            <fpage>218</fpage>
            <page-range>218-21</page-range>
            <pub-id pub-id-type="pmid">18563684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doelken</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of unexpandable lung due to pleural disease.</article-title>
            <source>Am J Med Sci</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>335</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-5</page-range>
            <pub-id pub-id-type="pmid">18195579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yim</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopic management of pleural effusions revisited.</article-title>
            <source>Aust N Z J Surg</source>
            <year>1995</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>308</fpage>
            <page-range>308-11</page-range>
            <pub-id pub-id-type="pmid">7741671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halstead</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Venkateswaran</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Charman</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Goddard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>314</fpage>
            <page-range>314-20</page-range>
            <pub-id pub-id-type="pmid">15780570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Soong</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.</article-title>
            <source>J Thorac Oncol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>1</volume>
            <issue>5</issue>
            <fpage>460</fpage>
            <page-range>460-7</page-range>
            <pub-id pub-id-type="pmid">17409900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Combined atelectasis of right upper and middle lobes: a clinical study of 15 cases.</article-title>
            <source>Zhonghua Yi Xue Za Zhi (Taipei)</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>359</fpage>
            <page-range>359-68</page-range>
            <pub-id pub-id-type="pmid">1659936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurney</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Atypical manifestations of pulmonary atelectasis.</article-title>
            <source>J Thorac Imaging</source>
            <year>1996</year>
            <season>Summer</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>165</fpage>
            <page-range>165-75</page-range>
            <pub-id pub-id-type="pmid">8784730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bibby</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Halford</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Fonseka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>The Prevalence and Clinical Relevance of Nonexpandable Lung in Malignant Pleural Mesothelioma. A Prospective, Single-Center Cohort Study of 229 Patients.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>1273</fpage>
            <page-range>1273-1279</page-range>
            <pub-id pub-id-type="pmid">31189069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nonexpandable Lung: More Than Just a Call from Radiology.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>1240</fpage>
            <page-range>1240-1242</page-range>
            <pub-id pub-id-type="pmid">31573341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30529.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heidecker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of pleural effusions after coronary artery bypass grafting surgery.</article-title>
            <source>Clin Chest Med</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-83</page-range>
            <pub-id pub-id-type="pmid">16716818</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
